Hedong Han

Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis

Yimin Wang, Hedong Han, Fang Zhang et al. · British Journal of Cancer · 2022 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Prevalence of Atrial Fibrillation in Hospital Encounters With End-Stage COPD on Home Oxygen

Xiaochun Xiao, Hedong Han, Cheng Wu et al. · CHEST Journal · 2019 · 44 citations

Medicine, Cardiology, Internal Medicine +7

Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect

Stephen D. Walter, Gordon Guyatt, Dirk Bassler et al. · Statistics in Medicine · 2019 · 42 citations

Public Health, Biostatistics, Clinical Epidemiology +15

Dynamic statistical model for predicting the risk of death among older Chinese people, using longitudinal repeated measures of the frailty index: a prospective cohort study

Qi Chen, Bihan Tang, Yinghong Zhai et al. · Age and Ageing · 2020 · 31 citations · Full text

Medicine, Biostatistics, Geriatric Medicine +17

Clinical impact of first‐line <scp>PD</scp>‐1 or <scp>PD‐L1</scp> inhibitors combined with chemotherapy in extensive‐stage <scp>small cell lung cancer</scp> patients: A real‐world multicenter propensity score‐matched study

Jingyuan Xie, Mo Chen, Hedong Han et al. · Thoracic Cancer · 2023 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17